NEUROPATHOLOGY, an esteemed journal published by WILEY, is a pivotal platform in the fields of medicine and neurology, focusing on the intricate relationship between pathology and neurological disorders. Established in 1993 and continually evolving until 2024, the journal holds a notable presence within the academic community, as evidenced by its current Q2 ranking in several categories including Medicine (Miscellaneous), Neurology (Clinical), and Pathology and Forensic Medicine. With a Scopus ranking placing it within the top 30% of its field, NEUROPATHOLOGY serves as a vital resource for researchers, healthcare professionals, and students dedicated to advancing their knowledge of neuropathological processes. Although not an Open Access journal, it ensures accessibility to cutting-edge research and insights that shape contemporary understanding and clinical practice. Its robust impact factor underscores the journal's critical role in disseminating innovative findings within the realms of neurology and pathology, making it an essential read for those at the forefront of medical research.

BRAIN RESEARCH is a premier journal published by Elsevier, specializing in the intricate domains of neuroscience, developmental biology, and molecular biology. Established in 1966, this esteemed publication has become a cornerstone for researchers, professionals, and students dedicated to advancing our understanding of brain function and disorders. With an impressive impact factor and a consistent presence in the Q2 quartiles across key categories—such as Developmental Biology, Neurology, and Neuroscience—it stands out as an essential resource for disseminating innovative research and pioneering insights. The journal's scope encompasses both clinical and fundamental studies, fostering a multidisciplinary approach to the complexities of neural systems. Although it is not an open-access journal, BRAIN RESEARCH provides a vital platform for sharing progressive findings that can inspire future studies and contribute significantly to the evolutionary discourse in neuroscience. Based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, BRAIN RESEARCH continues to shape the landscape of neuroscience research, inviting submissions that explore the latest discoveries and therapeutic strategies.

REDOX REPORT is a peer-reviewed academic journal published by Taylor & Francis Ltd, focusing on the latest advancements in the fields of biochemistry, clinical biochemistry, and physiology. Since its inception in 1996 and transitioning to an Open Access model in 2018, this journal has aimed to disseminate high-quality research findings and foster discussions within the scientific community. Positioned in the Q2 quartile across several relevant categories, including Biochemistry, Cell Biology, and Clinical Biochemistry, REDOX REPORT is recognized for its commitment to impactful research. The journal plays a crucial role in bridging the gap between fundamental biochemical research and its clinical applications, making it an essential resource for researchers, professionals, and students alike. With a consistent publication record extending to 2024, REDOX REPORT is dedicated to featuring cutting-edge studies that advance our understanding of redox biology, thereby contributing significantly to the ongoing dialogue in the life sciences.

The JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, published by Elsevier GmbH, stands as a leading platform for disseminating pivotal research in the interdisciplinary field that bridges biochemistry, inorganic chemistry, and molecular medicine. With an impact factor reflective of its high-quality submissions and significant contribution to the scientific community, this journal currently holds a Q2 ranking in Biochemistry and a Q1 ranking in Inorganic Chemistry, underlining its esteemed status among peers. Since its inception in 1995 and continuing through to 2024, the journal has fostered a dynamic discourse on the fundamental roles of trace elements in biological systems, incorporating studies that range from their biochemical functions to their impact on health and disease. Researchers, professionals, and students alike can access a wealth of knowledge, missing Open Access options notwithstanding, making it indispensable for those at the forefront of scientific investigation in medicine and biology.

STRESS - THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS, published by Taylor & Francis Ltd, is an esteemed open-access journal dedicated to advancing our understanding of stress and its biological underpinnings. Established in 1996 and continuing until 2024, this journal is pivotal in the exploration of stress across multiple dimensions, including its impact on mental health, neurobiology, and endocrine systems. With an impressive categorization in Q2 and Q3 quartiles across various fields such as Behavioral Neuroscience, Psychiatry, and Physiology, STRESS ranks commendably within its discipline, positioning itself as a vital resource for researchers and professionals alike. As of 2022, the journal's open access policy enhances visibility and accessibility, fostering a broader dissemination of knowledge. The journal invites submissions from a diverse range of disciplines, aiming to bridge gaps across fields and encourage interdisciplinary collaboration. By addressing the multifaceted nature of stress, STRESS remains essential for those eager to contribute to this dynamic and critical area of research.

Frontiers in Aging Neuroscience, published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to the field of aging neuroscience, with its ISSN being 1663-4365. Since its inception in 2009, this journal has provided a platform for researchers to disseminate their findings on the neurological aspects of aging, addressing critical issues that impact cognition and overall brain health in the elderly population. With a commendable 2023 impact factor, the journal ranks in the Q2 category in both Aging and Cognitive Neuroscience, positioning it among the top-tier publications in these fields. Notably, it is recognized within Scopus, ranking #32 out of 115 in Neuroscience (Cognitive Neuroscience) and #20 out of 38 in the Aging sector, with corresponding percentiles of 72nd and 48th, respectively. As an open-access journal, it promotes unrestricted access to research findings, fostering collaboration and innovation among the academic community. Researchers, professionals, and students alike can explore cutting-edge studies that contribute to understanding the complexities of neurological aging and work towards improving cognitive health in an aging society.

BMC NEUROSCIENCE is a prominent open access journal dedicated to the dissemination of high-quality research within the dynamic and rapidly evolving field of neuroscience. Published by BMC, a well-respected leader in open access publishing, this journal facilitates the free exchange of knowledge since its inception in 2000. With the ISSN 1471-2202, BMC NEUROSCIENCE aims to address the diverse interests of the neuroscience community by covering a broad spectrum of topics, ranging from cellular and molecular neuroscience to general neurological studies, thus appealing to researchers, professionals, and students alike. Although it currently holds a Q4 ranking in Cellular and Molecular Neuroscience and a Q3 rank in miscellaneous Neuroscience categories, its commitment to advancing the understanding of brain function and disorders remains steadfast. The journal features a user-friendly Open Access model, ensuring that critical research findings are readily accessible to everyone, fostering collaboration and innovation in the field. As the journal continues to evolve towards its convergence years of 2024, it aspires to enhance its impact and global reach, making it a valuable resource for anyone interested in advancing neuroscience research.

MOLECULAR THERAPY, published by CELL PRESS, is a distinguished journal in the field of molecular biology and therapy, renowned for its significant contributions to drug discovery, genetics, and pharmacology since its inception in 2000. This prestigious journal, which holds a commendable position in the Q1 category across multiple disciplines including Drug Discovery, Molecular Medicine, and Molecular Biology, facilitates cutting-edge research and innovative therapies that aim to improve patient outcomes. With an impressive Scopus ranking that places it among the top journals in its field—such as rank #6 in Drug Discovery and #8 in Pharmacology—MOLECULAR THERAPY is crucial for researchers, professionals, and students seeking to advance their understanding and application of molecular techniques. The journal welcomes high-quality submissions that explore the therapeutic potential of molecular mechanisms, fostering a collaborative spirit within the scientific community to push the boundaries of modern medicine.

Turkish Journal of Neurology, published by GALENOS PUBL HOUSE, is a pivotal open-access journal established in 2004, dedicated to advancing the field of neurology. Renowned for its inclusive approach, this journal serves as a vital platform for researchers and clinicians to share their findings and insights related to neurological disorders and clinical practices, with an emphasis on enhancing the understanding of various neurological conditions affecting populations in Turkey and beyond. Although it holds a Q4 rank in Neurology (Clinical) as per the 2023 category quartiles, the journal's commitment to fostering knowledge exchange remains steadfast, aiming to bridge gaps in clinical research and practice. With an ISSN of 1301-062X and an E-ISSN of 1309-2545, it is indexed in Scopus, ranking 349 out of 400, reflecting its growing presence in the academic sphere. Located in Istanbul, Turkey, the journal invites submissions from both emerging and established researchers to contribute to its diverse content, thereby enhancing its impact on the local and international neurology community.

BIOFACTORS, an esteemed journal published by Wiley, serves as a pivotal resource in the fields of Biochemistry, Clinical Biochemistry, and Molecular Medicine. With ISSN 0951-6433 and E-ISSN 1872-8081, the journal has established its reputation since its inception in 1988, showcasing a rich history of scientific inquiry and innovation. Recognized for its high academic standards, it currently holds a Q1 ranking in key categories, including Biochemistry and Medicine (miscellaneous), and ranks in the top 10% for Clinical Biochemistry according to Scopus metrics, reflecting its impact and influence in the scientific community. Although it does not offer Open Access, BIOFACTORS provides researchers the opportunity to publish and disseminate high-quality studies that advance our understanding of biological factors and their clinical implications. The journal actively encourages contributions that bridge the gap between laboratory findings and clinical applications, making it a vital platform for both seasoned researchers and emerging scholars in the life sciences.